Bas Ebaid
Clinical Oncology Society of Australia Annual Scientific Meeting 2023
Days
Wednesday, 1st November
Thursday, 2nd November
Friday, 3rd November
Search
Speakers
Bas Ebaid
Abstracts this author is presenting:
Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) vs treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775
—
Lunch, Poster Viewing, Exhibition & COSA Group Meetings